1. Home
  2. JUNS vs NCV Comparison

JUNS vs NCV Comparison

Compare JUNS & NCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JUNS
  • NCV
  • Stock Information
  • Founded
  • JUNS 2015
  • NCV 2003
  • Country
  • JUNS United States
  • NCV United States
  • Employees
  • JUNS N/A
  • NCV N/A
  • Industry
  • JUNS
  • NCV Finance Companies
  • Sector
  • JUNS
  • NCV Finance
  • Exchange
  • JUNS NYSE
  • NCV Nasdaq
  • Market Cap
  • JUNS 281.4M
  • NCV 321.7M
  • IPO Year
  • JUNS 2024
  • NCV N/A
  • Fundamental
  • Price
  • JUNS $0.84
  • NCV $13.92
  • Analyst Decision
  • JUNS
  • NCV
  • Analyst Count
  • JUNS 0
  • NCV 0
  • Target Price
  • JUNS N/A
  • NCV N/A
  • AVG Volume (30 Days)
  • JUNS 602.5K
  • NCV 405.1K
  • Earning Date
  • JUNS 03-04-2025
  • NCV 01-01-0001
  • Dividend Yield
  • JUNS N/A
  • NCV 12.48%
  • EPS Growth
  • JUNS N/A
  • NCV N/A
  • EPS
  • JUNS N/A
  • NCV N/A
  • Revenue
  • JUNS N/A
  • NCV N/A
  • Revenue This Year
  • JUNS N/A
  • NCV N/A
  • Revenue Next Year
  • JUNS N/A
  • NCV N/A
  • P/E Ratio
  • JUNS N/A
  • NCV N/A
  • Revenue Growth
  • JUNS N/A
  • NCV N/A
  • 52 Week Low
  • JUNS $0.78
  • NCV $2.84
  • 52 Week High
  • JUNS $19.51
  • NCV $3.59
  • Technical
  • Relative Strength Index (RSI)
  • JUNS N/A
  • NCV 40.15
  • Support Level
  • JUNS N/A
  • NCV $13.69
  • Resistance Level
  • JUNS N/A
  • NCV $14.23
  • Average True Range (ATR)
  • JUNS 0.00
  • NCV 0.25
  • MACD
  • JUNS 0.00
  • NCV -0.04
  • Stochastic Oscillator
  • JUNS 0.00
  • NCV 25.27

About JUNS JUPITER NEUROSCIENCES INC

Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.

About NCV Virtus Convertible & Income Fund of Beneficial Interest

Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.

Share on Social Networks: